CDKN2A and ovarian carcinoma: To verify the effect of the pTUNE-CDKN2A/p16-A148T and pTUNE-CDKN2A/p16-wild-type vectors, a CDKN2A homozygous deletion human ovarian cancer cell line, SKOV3, was selected (8).